[Psychiatric disorders after a single 3,4-methylenedioxyethamphetamine (MDE, "Eve") and tetrahydrocannabinol (cannabis) use]. 1996

H J Assion, and F Heinemann
Neurologische Abteilung, St.-Josef-Krankenhaus Moers, Oberhausen.

We report on a single intake of 3,3-methylenedioxyethamphetamine (MDE, "Eve") and tetrahydrocannabinol (cannabis). Because of the increasing abuse of "designer-drugs" and the rare reports on MDE the psychopathology after intake of MDE and cannabis is presented.

UI MeSH Term Description Entries
D011605 Psychoses, Substance-Induced Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance. Psychoses, Drug,Psychoses, Toxic,Substance-Induced Psychoses,Toxic Psychoses,Drug Psychoses,Psychoses, Substance Induced,Substance Induced Psychoses
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013759 Dronabinol A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound. THC,Tetrahydrocannabinol,delta(9)-THC,9-ene-Tetrahydrocannabinol,Marinol,Tetrahydrocannabinol, (6a-trans)-Isomer,Tetrahydrocannabinol, (6aR-cis)-Isomer,Tetrahydrocannabinol, (6aS-cis)-Isomer,Tetrahydrocannabinol, Trans-(+-)-Isomer,Tetrahydrocannabinol, Trans-Isomer,delta(1)-THC,delta(1)-Tetrahydrocannabinol,delta(9)-Tetrahydrocannabinol,9 ene Tetrahydrocannabinol,Tetrahydrocannabinol, Trans Isomer
D015104 3,4-Methylenedioxyamphetamine An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally. 3,4 Methylenedioxyamphetamine
D015198 Designer Drugs Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines. Customized Drug,Customized Drugs,Designer Drug,Drug, Customized,Drug, Designer,Drugs, Customized,Drugs, Designer

Related Publications

H J Assion, and F Heinemann
December 1992, Biological psychiatry,
H J Assion, and F Heinemann
June 1993, Anaesthesia,
H J Assion, and F Heinemann
June 1998, The American journal of forensic medicine and pathology,
H J Assion, and F Heinemann
October 1987, Pharmacology, biochemistry, and behavior,
H J Assion, and F Heinemann
July 2007, Neurosciences (Riyadh, Saudi Arabia),
H J Assion, and F Heinemann
June 2018, La Revue du praticien,
H J Assion, and F Heinemann
June 2010, Psychiatria Danubina,
H J Assion, and F Heinemann
October 2016, The lancet. Psychiatry,
Copied contents to your clipboard!